Jin Seok Kim - Publications, H-index & Citations

Jin Seok Kim

Yonsei University College of Medicine

54H指数

784论文数

1.3W被引数

收录论文 149

发表时间

Comprehensive High-Sensitivity Mutation Profiling in MPNs: Diagnostic and Prognostic Implications

Cancers

IF4.4

2026-08-15

OAAI

Namsoo Kim; Yehyun Kang; Hye Won Kook; Haerim Chung; Ji Eun Jang; Seung-Tae Lee; Jaewoo Song; Jin Seok Kim; Jong Rak Choi; June-Won Cheong; Saeam Shin

Bosmolisib (BR101801), a novel PI3K-δ/γ and DNA-PK inhibitor for relapsed/refractory patients with peripheral T-cell lymphoma: a phase I study Bosmolisib (BR101801)，一种新型PI3K-δ/γ和DNA-PK抑制剂，用于外周T细胞淋巴瘤复发/难治性患者：一项I期研究

Blood Cancer Journal

IF11.6

2026-08-07

OAAI

Tae Min Kim; Seok Jin Kim; Jin Seok Kim; Deok-Hwan Yang; Dok Hyun Yoon; Won Sik Lee; Eunyoung Lee; Jeong-Ok Lee; Ahmad Hatem Mattour; Jorge Chaves; Bong-Seog Kim

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study 移植不适格多发性骨髓瘤患者中硼替佐米维持治疗在VMP诱导后的真实世界有效性：一项目标试验模拟研究

Annals of Hematology

IF2.4

2026-03-23

OAAI

Jung Yeon Lee; Suein Choi; Seungpil Jung; Sung-Soo Park; Jin Seok Kim; Seung-Hwan Shin; Young-Woo Jeon; Seung-Ah Yahng; Je-Jung Lee; Hyo Jung Kim; Gyeong-Won Lee; Hyeon-Seok Eom; Min Kyoung Kim; Yundeok Kim; Jihyun Kwon; Chang-Ki Min

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study 疗效、安全性以及健康相关生活质量在非移植适应症的 newly diagnosed multiple myeloma 患者接受硼替佐米维持治疗中的应用：韩国骨髓瘤工作组 KMMWP-174 研究

Haematologica

IF7.9

2026-01-01

OAAI

Lee, Jung Yeon; Jung, Seungpil; Choi, Suein; Park, Sung-Soo; Kim, Jin Seok; Lee, Je-Jung; Park, Seong Kyu; Kim, Hyo Jung; Lee, Gyeong-Won; Park, Young Hoon; Eom, Hyeon-Seok; Kim, Jeong-A; Kim, Min Kyoung; Kim, Yundeok; Shin, Ho-Jin; Lee, Ho Sup; Kwon, Jihyun; Min, Chang-Ki

Perspectives on anti-BCMA bispecific antibodies use in multiple myeloma–experience from Asian countries 关于抗BCMA双特异性抗体在多发性骨髓瘤中的使用——来自亚洲国家的经验

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-10-11

PREAI

Cinnie Soekojo; Shimin Jasmine Chung; Ming-Tao Tsai; Wenming Chen; Jeffrey Huang; Jin Seok Kim; Dong-Gun Lee; Chang Ki Min; Kazuhito Suzuki; Subramanian Swaminathan; Hiroyuki Takamatsu; Daryl Tan; Uday Yanamandra; Chandramouli Nagarajan; Wee Joo Chng

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)随机化III期研究：比较泊马利度胺联合环磷酰胺、地塞米松与泊马利度胺联合地塞米松治疗复发或难治性骨髓瘤的疗效——一项亚洲骨髓瘤网络研究（AMN003）

Blood Cancer Journal

IF11.6

2025-10-06

OAAI

Jin Seok Kim; Yang Song; Wei-Ying Jen; C. S. Chim; Je-Jung Lee; Sung-Soo Yoon; Soo Chin Ng; Gin Gin Gan; Hiroshi Handa; Jae Hoon Lee; Kihyun Kim; Shigeki Ito; Jeffrey Shang-Yi Huang; Chang Ki Min; Melissa Ooi Gaik Ming; Sanjay de Mel; Cinnie Soekojo; Xinhua Li; Neha Awasthi; Yogesh Pokharkar; Brian GM Durie; Wee-Joo Chng

Wafer-Scale Homogenous Growth of Tungsten Disulfide via Promoter-Assisted Metal–Organic Chemical Vapor Deposition 通过助催化剂辅助的金属有机化学气相沉积法实现钨二硫化物的晶圆级均质生长

ACS Materials Letters

IF8.7

2025-10-01

OAAI

Do Hyoung Koo; Jung Hoon Kang; Jin Seok Kim; Jihoon Chang; Ki Jae Jang; Sol Lee; Yangjin Lee; Kwanpyo Kim; Gunuk Wang; Yong-Sung Kim; Donghun Lee; Chul-Ho Lee

Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup 浆细胞疾病中的影像学检查——亚洲骨髓瘤网络骨影像工作组共识建议

lancet regional health western pacific

IF0

2025-06-01

OAAI

Chandramouli Nagarajan; Natasha Fay Anthony; Jens Hillengass; Seok Jin Kim; Chutima Kunacheewa; Jay T. Datukan; Gin Gin Gan; Vo Thi Thanh Binh; James Chim; Jeffery S.Y. Huang; Wenming Chen; Kihyun Kim; S. Vincent Rajkumar; Brian G.M. Durie; Wee Joo Chng; Masahiro Abe

Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera® in low-tumor-burden follicular lymphoma: the FLINTER study 利妥昔单抗生物类似药（DRL_RI）与MabThera®在低肿瘤负荷滤泡性淋巴瘤中的有效性和安全性：FLINTER研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2025-05-24

OAAI

Narendra Maharaj; Dharma Rao Uppada; Anand Eswaraiah; Ranjith Kakkattu; Pramod Reddy; Volha A. Kalenik; David Belada; Ana Oliveira Ramos; Jin Seok Kim; Yauheni V. Baranau

Real-World Use of carfilzomib-lenalidomide-dexamethasone (KRd) and carfilzomib-dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: A Prospective Multicenter Observational Study 亚太地区复发/难治性多发性骨髓瘤中卡非佐米-来那度胺-地塞米松（KRd）和卡非佐米-地塞米松（Kd）的真实世界应用：一项前瞻性多中心观察性研究

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-05-07

OAAI

Hang Quach; Kihyun Kim; Raymond Siu Ming Wong; Si Yun Melinda Tan; Ming-Chung Wang; Kopei Chang; Megan Braunlin; Mihaela Talpes; Rani Najdi; Jin Seok Kim

Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review 亚洲阵发性夜间血红蛋白尿症患者血栓栓塞的预防与管理：一项叙事性综述

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-03-11

OAAI

Ueda, Yasutaka; Chou, Wen-Chien; Goh, Yeow-Tee; Rojnuckarin, Ponlapat; Kim, Jin Seok; Wong, Raymond Siu Ming; Lee Wong, Lily Lee; Jang, Jun Ho; Chiou, Tzeon-Jye; Kanakura, Yuzuru; Lee, Jong Wook

Development of Red Flags Index for Crohn's Disease in the Korean population

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-22

PREAI

Kim, O.; Kim, S. H.; Lee, H. J.; Im, J. P.; Kim, B. G.; Kim, J. S.; Koh, S. J.

Efficacy and Safety of Rituximab Biosimilar (DRL-RI) Versus Mabthera in Low Tumor Burden Follicular Lymphoma: The Flinter Study 利妥昔单抗生物类似药（DRL-RI）与Mabthera在低肿瘤负荷滤泡性淋巴瘤中的有效性与安全性比较：Flinter研究

BLOOD

IF23.1

2024-11-05

PREAI

Maharaj, Narendra; Uppada, Dharma Rao; Eswaraiah, Anand; Kakkattu, Ranjith; Reddy, Pramod; Kalenik, Volha A.; Belada, David; Oliveira, Ana C.; Kim, Jin Seok; Baranau, Yauheni, V

Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry

EUROPEAN HEART JOURNAL

IF35.6

2024-10-28

PREAI

Choi, J., I; Jeong, J. H.; Min, K. J.; Kim, S. J.; Rho, S. Y.; Choi, C. U.; Han, G. S.; Song, J. H.; Lee, E. J.; Lee, S. W.; Kim, Y. H.

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-06-25

PREAI

Scheinberg, Phillip; Cle, Diego Villa; Kim, Jin Seok; Nur, Erfan; Yenerel, Mustafa N.; Barcellini, Wilma; Bonito, Debora; Giai, Valentina; Hus, Marek; Lee, Yoojin; Lekue, Cristina Barrenetxea; Panse, Jens; Ueda, Yasutaka; Buatois, Simon; Gentile, Brittany; Kiialainen, Anna; Patel, Himika; Sreckovic, Sasha; Uguen, Marianne; Edwards, John; Nagy, Zsolt; Kulasekararaj, Austin G.

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study

HAEMATOLOGICA

IF7.9

2024-06-06

OAAI

Lee, Ji Hyun; Choi, Jimin; Min, Chang-Ki; Park, Sung-Soo; Jo, Jae-Cheol; Lee, Yoo Jin; Kim, Jin Seok; Eom, Hyeon-Seok; Jung, Jongheon; Moon, Joon Ho; Cho, Hee Jeong; Lee, Myung-won; Yoon, Sung-Soo; Byun, Ja Min; Lee, Jae Hoon; Lee, Je-Jung; Jung, Sung-Hoon; Shin, Ho-Jin; Kim, Do Young; Yi, Jun Ho; Lee, Seung-Shin; Do, Young Rok; Yoon, Dok Hyun; Cho, Hyungwoo; Lee, Won Sik; Lee, Ho Sup; Uhm, Jieun; Kim, Hyo Jung; Jang, Hee Ryeong; Kim, Sung-Hyun; Kim, Kihyun

Long-term efficacy and safety of tucidinostat inpatients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results

HAEMATOLOGICA

IF7.9

2024-06-06

OAAI

Rai, Shinya; Kim, Won Seog; Ando, Kiyoshi; Choi, Ilseung; Izutsu, Koji; Tsukamoto, Norifumi; Maruyama, Dai; Tsukasaki, Kunihiro; Kuroda, Junya; Ando, Jun; Hidaka, Michihiro; Koh, Youngil; Kato, Hisashi; Uchida, Toshiki; Yang, Deok Hwan; Ishitsuka, Kenji; Ishizawa, Kenichi; Kim, Jin Seok; Lee, Hong Ghi; Minami, Hironobu; Eom, Hyeon Seok; Kurosawa, Mitsutoshi; Lee, Jae Hoon; Lee, Jong Seok; Lee, Won Sik; Nagai, Hirokazu; Shindo, Takero; Yoon, Dok Hyun; Yoshida, Shinichiro; Gillings, Mireille; Onogi, Hiroshi; Tobinai, Kensei

The novel eIF4A inhibitor potently synergizes with BCL2 inhibitor in high grade B-cell lymphoma with MYC and BCL2 rearrangements through regulating UPR

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Seol, So-Young; Park, Chung Hyun; Kim, Soo Jeong; Chung, Haerim; Cho, Hyunsoo; Kim, Jin Seok; Kim, Yu Ri

Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study 新生弥漫大b细胞淋巴瘤免疫球蛋白基因重排累及骨髓的临床意义: 一项多中心回顾性研究

FRONTIERS IN ONCOLOGY

IF3.3

2024-02-12

OAAI

Kim, Yu Ri; Shin, Ho Jin; Yhim, Ho-Young; Yang, Deok-Hwan; Park, Yong; Lee, Ji Hyun; Lee, Won-Sik; Do, Young Rok; Mun, Yeung-Chul; Kim, Dae Sik; Kim, Jin Seok

Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab daratumumab治疗的结外自然杀伤/T细胞淋巴瘤患者的免疫分析

ANNALS OF HEMATOLOGY

IF2.4

2024-01-18

OAAI

Qing, Min; Zhou, Tianyuan; Perova, Tatiana; Abraham, Yann; Sweeney, Cheryl; Krevvata, Maria; Zhang, Xiaokang; Qi, Ming; Gao, Grace; Kim, Tae Min; Yao, Ming; Cho, Seok-Goo; Eom, Hyeon Seok; Lim, Soon Thye; Yeh, Su-peng; Kwong, Yok Lam; Yoon, Dok Hyun; Kim, Jin Seok; Kim, Won Seog; Zhou, Longen; Attar, Ricardo; Verona, Raluca I.

研究方向